| HOME >> BIOLOGY >> TECHNOLOGY |
Conference Call Scheduled for July 22, 2008 at 11:00 am EASTERN
DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc
(Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products
for the point-of-care and clinical laboratory markets, will report
financial results for the second quarter of fiscal year 2008 on Tuesday,
July 22, 2008. The Company has scheduled a conference call for that same
day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the
results of the quarter.
Interested parties can access the call by dialing:
USA: 877-356-5706
International: +1-706-643-0580
A simultaneous webcast of the call can be accessed at:
http://www.videonewswire.com/event.asp?id=50024
A replay of the call can be accessed until July 25, 2008 by dialing:
USA: 1-800-642-1687
International: +1-706-645-9291
Conference ID #: 56210288
The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024
About Trinity Biotech plc
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires,
manufactures and markets over 500 diagnostic products for the point-of-care
and clinical laboratory segments of the diagnostic market. The broad line
of test kits are used to detect infectious diseases, sexually transmitted
diseases, blood coagulation disorders, and autoimmune diseases. Trinity
Biotech sells worldwide in over 80 countries through its own sales force
and a network of international distributors a
'/>"/>
| SOURCE Trinity Biotech plc Copyright©2008 PR Newswire. All rights reserved |